Search Results 2521-2530 of 17574 for GERD

  1. A Study to Analyze Whole Methylome for Identification of Epigenetic Variations in Undiagnosed Congenital Disorders - Mayo Clinic

    The purpose of this study is to analyze genome-wide methylation patterns in DNA from patients with suspected hereditary disorders but for whom all previous ...

  2. Functional Epigenomics Lab - Mayo Clinic Research

    Dr. Maia's Functional Epigenomics Lab at Mayo Clinic investigates epigenomic profiling, chromatin, biomarker discovery and tumor-specific enhancers.

  3. Mike M. Bierle, M.D. - Doctors and Medical Staff - Mayo Clinic

    Education · 2016. ResidentInternal Medicine, Programs in Rochester, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine · 2013. MD ...

  4. Publications - Stacy D. D'Andre, M.D. - Mayo Clinic

    Olaparib With or Without Cediranib Versus Platinum-Based Chemotherapy in Recurrent Platinum-Sensitive Ovarian Cancer (NRG-GY004): A Randomized, Open-Label, ...

  5. Genetics Epigenetics and Metabolomics Core - Mayo PKD Clinical Database

    The Genetics, Epigenetics and Metabolomics Core at Mayo Clinic offers access to the Mayo PKD Clinical Database to study autosomal dominant polycystic kidney ...

  6. Publications - Moira Hilscher, M.D. - Mayo Clinic

    Mortality and morbidity after combined heart and liver transplantation in the failing Fontan: An updated dual center retrospective study. Clin Transplant. 2024; ...

  7. Postdoctoral Opportunities - Cellular and Molecular Physiology of Gastrointestinal Disorders Laboratory - Mayo Clinic Research

    The Cellular and Molecular Physiology of Gastrointestinal Disorders Laboratory led by Gianrico Farrugia, M.D., offers training for researchers focusing on the ...

  8. Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis - Mayo Clinic

    The purose of this study is to assess the effectiveness and safety of rifaximin SSD-40mg IR for the delay of the first episode of overt hepatic encephalopathy ( ...

  9. Artificial intelligence informs solutions for gastric cancer challenges - Mayo Clinic

    Mayo Clinic researchers have found a 32-gene signature that is a promising prognostic and predictive biomarker for patients with gastric cancer.

  10. Gastric Bypass Clinical Trials - Mayo Clinic Research

    Exendin-(9,39) has been shown to have effects on beta-cell function, and after gastric bypass, to accelerate gastrointestinal transit. - infused at rates of ...